Related Experiment Video
Updated: Aug 2, 2026

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
Published on: August 18, 2014
Omeprazole and SCH 28080 inhibit acid secretion by the turtle urinary bladder
1Division of Nephrology, VAMC, Northport, N.Y. 11768.
Omeprazole and SCH 28080 inhibit acid secretion in turtle bladders, but do not affect potassium-dependent transport. These drugs likely inhibit the vacuolar H(+)-ATPase, not the gastric H+/K(+)-ATPase.
Area of Science:
- Physiology
- Renal Physiology
- Ion Transport
Background:
- The distal nephron utilizes vacuolar-type H(+)-ATPase and gastric-type H(+)/K(+)-ATPase for acidification.
- The presence and role of H(+)/K(+)-ATPase in turtle bladder acidification remain unclear.
Purpose of the Study:
- To investigate the potential presence of gastric-type H(+)/K(+)-ATPase in turtle bladders.
- To determine the mechanism of acid secretion in turtle bladders using specific inhibitors.
Main Methods:
- Examined acid secretion dependence on mucosal potassium (K+).
- Assessed effects of omeprazole and SCH 28080 on electrogenic H+ secretion (RSCC).
- Investigated drug effects under conditions of inhibited acid secretion and altered K+ levels.
Main Results:
- Omeprazole and SCH 28080 dose-dependently inhibited CO2-stimulated H+ secretion.
- Inhibition was independent of mucosal K+ and unaffected by prior inhibition of acid secretion.
- These drugs stimulated HCO3- secretion, suggesting a different transport mechanism.
Conclusions:
- Turtle bladder acid secretion is not mediated by H(+)/K(+)-ATPase due to K+ independence.
- Omeprazole and SCH 28080 likely inhibit the vacuolar H(+)-ATPase in turtle bladders.
- HCO3- secretion utilizes a distinct H+ transport mechanism separate from acid secretion.
More Related Videos
06:12Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015
08:53Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease II: Pathophysiology